oliceridine (Olinvyk) Report issue

Small molecule Approved FDA Fast Track FDA
AACT ChEMBL MeSH PubChem

Active Ingredient History

NOW
  • Now
Oliceridine, sold under the brand name Olinvyk, is an opioid medication that is used for the treatment of moderate to severe acute pain in adults. It is given by intravenous (IV) injection.   Wikipedia

Chemistry

  • SMILES: COc1ccsc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4
  • InChIKey: DMNOVGJWPASQDL-OAQYLSRUSA-N
  • Mol. Mass: 386.56
  • ALogP: 4.69
  • ChEMBL Molecule:
    oliceridine  
More Chemistry

Pharmacology

Drug Pricing (per unit)

United States

$13.0990 - $82.3400
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine | oliceridine | trv130 | trv-130

Organizations (10)

Research & Development (10)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (8)

Approved Indications (1)


 

Acute Pain (approved 2020)

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Acute Pain (Phase 4)

Burns (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

General Surgery (Phase 3)

Healthy Volunteers (Phase 1)

Pain (Phase 2)

Postoperative Nausea and Vomiting (Phase 4)

Respiratory Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial Organizations: 10

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue